<i><scp>CFTR</scp></i> founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis

Abstract

Together with other previously reported mutations, the specific founder mutation presented herein suggests a unique <i>CFTR</i> mutation spectrum in the southern Chinese populations, and this finding has vital implications for improving molecular testing and mutation-specific treatments for Chinese patients with CF.